DOW INC. DL-,01/ US2605571031 /
2024-05-20 8:19:16 AM | Chg. +0.130 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
54.340EUR | +0.24% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 38.37 bill.EUR | - | - |
GlobeNewswire
05-20
60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State ...
GlobeNewswire
02-13
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
GlobeNewswire
01-22
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
GlobeNewswire
2023-11-16
Dow Jones Appoints Global Agency Partners to Accelerate Marketing Transformation and Subscription Gr...
GlobeNewswire
2023-10-11
Dow Jones Risk & Compliance Completes ISAE 3000 Assurance for Ninth Consecutive Year
GlobeNewswire
2023-09-06
60 Degrees Pharmaceuticals to Participate in H.C. Wainwright 25th Annual Global Investment Conferenc...
GlobeNewswire
2021-11-17
Gildan Included on the 2021 Dow Jones Sustainability Index for the Ninth Consecutive Year